Overview

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is in non small-cell lung cancer stage IV et IIIB (T4 with pleural effusion) in elderly dependent patients with evaluation of the sequence Gemcitabine first line followed by Erlotinib when progression versus Erlotinib first line followed by Gemcitabine when progression
Details
Lead Sponsor:
Groupe Francais De Pneumo-Cancerologie
Treatments:
Erlotinib Hydrochloride
Gemcitabine